tyrosine has been researched along with Infections, Pseudomonas in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (45.45) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bienvenu, T; Burgel, PR; Chapron, J; Dusser, D; Gaitch, N; Génin, E; Girodon, E; Honoré, I; Hubert, D; Kanaan, R; Martinez, B; Viel, M | 1 |
| He, C; Kazmierczak, BI; Lan, L; Murray, TS | 1 |
| Connelly, R; Enkhbaatar, P; Hamahata, A; Herndon, DN; Lange, M; Nakano, Y; Schmalstieg, FC; Traber, DL; Traber, LD | 1 |
| Bannigan, J; Cadogan, E; Giles, S; Hopkins, N; McLoughlin, P | 1 |
| Burke, AS; Cox, RA; Enkhbaatar, P; Hawkins, HK; Komjáti, K; Mabley, JG; Murakami, K; Pacher, P; Salzman, AL; Schmalstieg, FC; Shimoda, K; Szabó, C; Traber, DL; Traber, LD; Zsengellér, Z | 1 |
| Gunning, Y; Hopkins, N; Laffey, JG; McLoughlin, P; O'Croinin, DF | 1 |
| Dóber, I; Klujber, L; Mestyán, J; Schultz, K; Soltész, G | 1 |
| Herndon, DN; Mason, AD; Pruitt, BA; Wilmore, DW | 1 |
| Hamilton-Miller, JM; Ogunnariwo, J | 1 |
| Loegering, DJ; Turinsky, J | 1 |
| Diena, BB; Tabuchi, K | 1 |
11 other study(ies) available for tyrosine and Infections, Pseudomonas
| Article | Year |
|---|---|
DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis.
Topics: Adolescent; Adult; Child; Child, Preschool; Cysteine; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dynactin Complex; Female; Genetic Predisposition to Disease; Humans; Incidence; Infant; Male; Middle Aged; Mutation, Missense; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sex Factors; Tyrosine; Young Adult | 2016 |
Pseudomonas aeruginosa OspR is an oxidative stress sensing regulator that affects pigment production, antibiotic resistance and dissemination during infection.
Topics: Amino Acid Substitution; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Female; Gene Deletion; Gene Expression Regulation, Bacterial; Glutathione Peroxidase; Hydrogen Peroxide; Mice; Mice, Inbred C57BL; Models, Biological; Mutagenesis, Site-Directed; Oxidative Stress; Pigments, Biological; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; Repressor Proteins; Signal Transduction; Stress, Physiological; Tyrosine; Virulence | 2010 |
Pulmonary microvascular hyperpermeability and expression of vascular endothelial growth factor in smoke inhalation- and pneumonia-induced acute lung injury.
Topics: Acute Lung Injury; Animals; Capillary Permeability; Disease Models, Animal; Female; Lung; Microcirculation; Nitric Oxide; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Circulation; Pulmonary Edema; Pulmonary Gas Exchange; RNA, Messenger; Sepsis; Sheep; Smoke Inhalation Injury; Time Factors; Tyrosine; Vascular Endothelial Growth Factor A | 2012 |
Type 2 nitric oxide synthase and protein nitration in chronic lung infection.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cell Count; Chronic Disease; Fluorescent Antibody Technique; Lung; Lung Diseases; Male; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pseudomonas Infections; Rats; Rats, Sprague-Dawley; Tyrosine | 2003 |
Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis.
Topics: Animals; Antithrombins; DNA Damage; Enzyme Inhibitors; Female; Hematocrit; Hemoglobins; Immunohistochemistry; Indoles; Lipid Peroxidation; Lung; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Poly(ADP-ribose) Polymerase Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sepsis; Sheep; Time Factors; Tyrosine | 2004 |
Anti-inflammatory effect of augmented nitric oxide production in chronic lung infection.
Topics: Animals; Arginine; Bronchoalveolar Lavage Fluid; Cell Count; Chronic Disease; Disease Models, Animal; Enzyme Inhibitors; Interleukin-1; Interleukin-6; Lung; Lung Diseases; Male; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pseudomonas Infections; Rats; Rats, Inbred WKY; Tyrosine; Vascular Endothelial Growth Factor A | 2006 |
Metabolic effects of septicaemia in newborn and young infants with particular reference to the plasma free amino acids.
Topics: Alanine; Amino Acids; Amino Acids, Branched-Chain; Bacterial Infections; Escherichia coli Infections; Glycine; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Phenylalanine; Proline; Pseudomonas Infections; Sepsis; Tyrosine | 1980 |
Abnormalities of phenylalanine and tyrosine kinetics. Significance in septic and nonseptic burned patients.
Topics: Adult; Burns; Fasting; Humans; Kinetics; Klebsiella Infections; Liver; Middle Aged; Muscle Proteins; Muscles; Phenylalanine; Pseudomonas Infections; Sepsis; Tyrosine | 1978 |
Brown- and red-pigmented Pseudomonas aeruginosa: differentiation between melanin and pyorubrin.
Topics: Anti-Bacterial Agents; Color; Culture Media; Drug Resistance, Microbial; Glutamates; Humans; Melanins; Microbial Sensitivity Tests; Pigments, Biological; Pseudomonas aeruginosa; Pseudomonas Infections; Species Specificity; Spectrophotometry; Tyrosine | 1975 |
Prostaglandin E2 and muscle protein turnover in Pseudomonas aeruginosa sepsis.
Topics: Animals; Aspirin; Cycloheximide; Dinoprostone; Indomethacin; Male; Muscle Proteins; Muscles; Prostaglandins E; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Inbred Strains; Tyrosine | 1985 |
The protective effect of Pseudomonas culture filtrates against experimental infection in mice.
Topics: Animals; Bacterial Vaccines; Culture Media; Filtration; Glucose; Immunization; Immunodiffusion; Lethal Dose 50; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Time Factors; Tyrosine; Ultrafiltration | 1974 |